Cat. No.: X24-08-YM292
Integrin inhibitor, Cyclo (RGDyK) trifluoroacetate, Purity ≥98%
Synonym: 250612-42-1; Cyclic Arg-Gly-Asp-D-Tyr-Lys; Cyclo(RGDyK); 2-[(2S,5R,8S,11S)-8-(4-Aminobutyl)-11-[3-(diaminomethylideneamino)propyl]-5-[(4-hydroxyphenyl)methyl]-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]acetic acid; 2,2,2-trifluoroacetic acid
- MDL: MFCD20134101
- CAS Number: 250612-42-1
- Compound CID: 129896716
Product Size
5 mg; 10 mg; 25 mg; 50 mg
Properties
Description
Cyclo (RGDyK) trifluoroacetate, soluble in DMSO, water and ethanol, is an effective cytoskeleton inhibitor, that has the ability to prevent the pathway of cytoskeletal signaling by inhibiting integrin. It targets the αVβ3 integrin.
Molecular Formula
C31H43F6N9O12
Targets
αvβ3 Integrin: 20 nM
Titer
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects
Solubility
In vitro: DMSO: 97 mg/mL (114.42 mM); Water: 97 mg/mL (114.42 mM); Ethanol: 19 mg/mL (22.41 mM)
Applications
Cyclo (RGDyK) trifluoroacetate is a cytoskeletal signaling inhibitor that can be used for its ability to disrupt integrin-mediated interactions.
Related Products
- Integrin inhibitor, Zaurategrast, Purity ≥98%
- Integrin inhibitor, Cilengitide trifluoroacetate, Purity ≥98%
- Integrin inhibitor, Cilengitide, Purity ≥98%
- Integrin inhibitor, Firategrast, Purity ≥98%
- Integrin inhibitor, Pyrintegrin, Purity ≥98%
- Integrin inhibitor, A-205804, Purity ≥98%
